HGH Fragment 176191 AOD9604 Peptide China Factory and Suppliers
High purity HGH Fragment 176-191 5MG available from leading China suppliers. Our factory specializes in AOD-9604 for lipolysis and metabolic research with 98% HPLC purity.
About this product
Product information from the supplier.
HGH Fragment 176-191, widely recognized in scientific literature as AOD-9604, is a high-precision synthetic peptide consisting of 16 amino acids. This specialized sequence is meticulously derived from the C-terminus of the human growth hormone (hGH), specifically engineered to target lipolysis and metabolic efficiency.
Unlike full-length growth hormone, HGH Fragment 176-191 is designed to stimulate fat loss and regulate metabolism without the systemic risks associated with insulin-related effects or broader growth-promoting triggers. It represents a sophisticated advancement in genetic engineering drug manufacturing, offering a targeted approach to metabolic research and pharmaceutical development.
Detailed Parameters
| Product Name | HGH Fragment 176-191 (AOD-9604) | Peptide Length | 16 Amino Acids |
|---|---|---|---|
| Source Sequence | hGH C-Terminus | Purity Level | ≥ 98% (HPLC) |
| Molecular Formula | C89H155N29O30 | CAS Number | Available upon request |
| Mechanism | Lipolysis Stimulation | Target Area | Adipose Tissue |
| Application | Biopharmaceutical Research | Storage Condition | -20°C / 2-8°C |
Key Advantages
Selective Action
Targets fat loss specifically without triggering the insulin-related effects found in full-length HGH.
Metabolic Regulation
Optimizes the body's ability to mobilize stored lipids and enhance metabolic rate in preclinical models.
High Purity
Manufactured under strict gene engineering standards to ensure maximum biological activity and consistency.
Reduced Side Effects
Eliminates the growth-promoting side effects typically associated with systemic growth hormone administration.
Precision Synthesis
Utilizes advanced solid-phase peptide synthesis for precise amino acid sequencing.
Research Grade
Fully validated for use in bio-pharmaceutical labs and metabolic disorder studies.
Product Gallery
Management Platforms
Batch Tracking
Complete traceability for every peptide batch from synthesis to final delivery.
QC Control
Rigorous HPLC and Mass Spectrometry testing for every shipment.
Stability Monitoring
Real-time monitoring of storage temperatures to preserve peptide integrity.
Order Automation
Streamlined procurement process for recurring research laboratory orders.
Inventory Sync
Real-time stock levels for various peptide concentrations and volumes.
Custom Synthesis
Tailored amino acid modifications based on specific research requirements.
Investment Return Comparison
| Feature | Full-Length hGH | HGH Fragment 176-191 |
|---|---|---|
| Lipolytic Activity | General | Highly Targeted |
| Insulin Impact | Significant Change | Negligible/None |
| Growth Effects | Systemic Growth | None |
| Research Focus | Endocrine Study | Metabolic/Fat Loss |
| Safety Profile | Broad Side Effects | Specific/Localized |
Frequently Asked Questions
The primary difference is selectivity. While standard HGH affects overall growth and insulin levels, Fragment 176-191 specifically targets fat loss and metabolism without those systemic growth effects.
It is produced using advanced synthetic peptide chemistry, mimicking the C-terminal sequence of the human growth hormone to ensure biological activity and high purity.
Yes, AOD-9604 is the commonly used designation for the modified HGH Fragment 176-191 used in pharmaceutical and metabolic research.
To maintain stability, it should be stored at -20°C for long-term storage or 2-8°C for short-term use, protected from light and moisture.
Unlike full-length hGH, Fragment 176-191 does not typically trigger the insulin-related effects that can lead to blood glucose fluctuations.
Industry standards for high-quality biological drug manufacturing typically require a purity of 98% or higher, verified via HPLC analysis.